NEW YORK (Reuters Health) – Including tirofiban (Aggrastat) in pre-hospital protocols can improve the outcomes of angioplasty for ST-segment elevation myocardial infarction (STEMI), according to randomized trial results.…
NEW YORK (Reuters Health) – In mice, treating primary respiratory syncytial virus (RSV) with the cysteinyl leukotriene 1 receptor antagonist montelukast reduces airway hyperresponsiveness and inflammation after RSV…
NEW YORK (Reuters Health) – When hypothyroid women become pregnant, they need to increase their levothyroxine dose by two tablets per week, or 29%, a new trial has…
NEW YORK (Reuters Health) – Heparin bridging while withholding warfarin before implantation of a heart rhythm device substantially increases the risk of bleeding, new research shows. By contrast,…
Actinic Keratoses (AKs) are precancerous growths on the skin, typically characterized by rough and dry skin lesions. In this video, Gary Goldenberg, MD, Assistant Professor of Dermatology and…
NEW YORK (Reuters Health) – Cerebral microbleeds increase the risk of intracerebral hemorrhage (ICH) in patients taking warfarin, a new study suggests. “These results have potentially worrying implications…
NEW YORK (Reuters Health) – High doses of oxytocin are more effective than low doses for labor augmentation, a new meta-analysis has shown. The higher-dose protocols shortened labor…
NEW YORK (Reuters Health) – The combination of the cholesterol uptake inhibitor ezetimibe and a statin is more effective than a statin alone for reducing LDL cholesterol in…
NEW YORK (Reuters Health) – Lipid-lowering therapy reduces cardiovascular events and all-cause mortality in patients with atrial fibrillation, according to a post hoc analysis of the AFFIRM study.…
NEW YORK (Reuters Health) – A single yearly oral dose of 500,000 international units of cholecalciferol (vitamin D) does not protect generally healthy older women from falls and…